Edition:
India

Lannett Company Inc (LCI.N)

LCI.N on New York Stock Exchange

5.35USD
1:31am IST
Change (% chg)

$-8.15 (-60.37%)
Prev Close
$13.50
Open
$6.00
Day's High
$6.45
Day's Low
$5.30
Volume
1,063,820
Avg. Vol
105,868
52-wk High
$30.35
52-wk Low
$5.30

Chart for

About

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June... (more)

Overall

Beta: 2.73
Market Cap(Mil.): $784.83
Shares Outstanding(Mil.): 37.28
Dividend: --
Yield (%): --

Financials

  LCI.N Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.03 -- --
ROI: -0.04 15.07 14.61
ROE: -0.10 16.59 16.33

BRIEF-Lannett Reports Q3 Adjusted Earnings Per Share $0.80

* LANNETT ANNOUNCES FISCAL 2018 THIRD-QUARTER FINANCIAL RESULTS

08 May 2018

BRIEF-Lannett Acquires Portfolio Of Generic Products From Endo International

* LANNETT ACQUIRES PORTFOLIO OF GENERIC PRODUCTS FROM ENDO INTERNATIONAL

07 May 2018

BRIEF-Lannett Appoints Patrick Lepore Chairman Of Board

* LEPORE WILL SUCCEED JEFFREY FARBER, WHO WILL REMAIN A MEMBER OF BOARD Source text for Eikon: Further company coverage:

30 Apr 2018

Competitors

  Price Chg
AbbVie Inc (ABBV.N) $97.63 -1.18
Pfizer Limited (PFIZ.NS) Rs2,987.20 --
Dr.Reddy's Laboratories Ltd (REDY.NS) Rs2,380.75 +16.60

Earnings vs. Estimates